Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XR-NTX for Opioid Relapse Prevention in Jail Releasees
NCT01180647Phase 3Completed
- Sponsor
- NYU Langone Health
- Start
- May 2010
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naltrexone in opioid use disorder (OUD), sponsored by NYU Langone Health. Started May 2010; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01180647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01180647.